Productions végétales

Productions végétales

l > Avian GHD genes and their use in methods for sex identification in birds (R Griffiths and B Tiwari, UK) Isis Innovation Ltd and the inventors N”...

151KB Sizes 0 Downloads 79 Views

l

> Avian GHD genes and their use in methods for sex identification in birds (R Griffiths and B Tiwari, UK)

Isis Innovation Ltd and the inventors N” WO 96139505. PCT. The invention provides for DNA sequences (introns and exons) encoding two genes located on the Z and W chromosomes of birds. These genes can be used to identify the sex of most birds (Class Aves). In addition, the genes control the sex of the birds, a genetic process which is initiated as an embryo.

les derniers brevets dkposes : morceaux choisis rdalist5e en collaboration avec I’lnpi

Novel inocula for administration to ruminant animals such as cattle or sheep are provided in order to immunize the animals and lessen the incidence of liver abscesses and/or foot rot therein. In one aspect, the invention pertains to an A e)iogenesderived vaccine including an inactivated cell culture product (eg, cell-elaborated supcrnatant) from A proge:elzer cell culture m a suitable carrier. In another aspect, the invention relates to a multivalent vaccine including at least first and second bacterial components in a carrier. the first component comprises an inactivated cell culture product of l%roh~~ct~YiMNl nrcYophorsfm...

> Genetic control of flowering (C Dean et a/, RU)

> lnhibin compositions and methods of enhancing production performance (WC Fioretti et a/,

John lnnes Centre Innovations Ltd and the inventors N” WO 96/38560, PCT.

US)

FC4

Agritech Technologies Ltd and the Board of Supervisors of Louisiana State University and Agricultural and Mechanical College N” WO 96140219. PCT. The present invention relates, in general, to a method of enhancing the production performance of avians, by administering to a bird a heterologous protein comprised of inhibin protein, or a fragment thereof, and a carrier protein. The present invention also relates to a method of enhancing the production performance of avians, by administering to a bird a fusion gene product comprising a gene encoded for the expression of CI-subunit avian inhibin protein, or a fragment thereof, and a gene encoded for the expression of a carrier protein... > Actinomyces pyogenes and Actinomyces pyogenedfusobacterium necrophorom vaccines for immunizing cattle and sheep (TG Nagaraja and M Chengappa, US)

Kansas State University Research Foundation N” WO 96140237, PCT.

genes

of Arabidopsis Bnzrsica FZJ~US are provided, enabling flowering characteristics, particularly timing of flowering, to be influenced in transgenit plants. Timing of flowering may be delayed or hastened using sense and antisense expression, also various mutants and alleles, including alternatively spliced forms.

tbalmnaand

> Sdquence ADN d’un gene de I’hydroxy-ph6nyl pyruvate dioxygenase et obtention de plantes contenant un gBne de I’hydroxy-ph6nyl pyruvate dioxygenase tol&antes Zi certains herbicides (A Sailland et a/, FR, RU)

Rh6ne-Poulenc Agrochimie et les inventeurs N” WO 96138567, PCT.

5 Batteries lactiques produisant des exopolysaccharides (F Stingele et B Mollet, CH)

Soci&+ des produits Nestle SA N” 750043, EP. Fragments gknomique

d’ADN codant

d’origine au moins

une enzyme impliquke dnns la biosynthtse d’un H’S, et capable suite j la transformation d’une bactPrie lactique de restaurer la production d’un EPS dans ladite backie n’en produisant pas initialement, ou de modifier la structure de I’EPS produit initialement par ladite bactkrie. ProtPines de la souche StYPptococcl4s tbeur?lophilus CNCM l-1590 codkes par le chrosome et qui sont impliquCes dans la biosynthke de I’EPS ayant la composition Glc:Cal:Gal-Nat= 1:2:1... > Pro&d6 de mise en 6vidence de microorganismes thermor&istants pouvant contaminer certaines denrees alimentaires (E Chrzavzez et R AufrBre, FR)

Ultra Propre Nutrition Industrie Recherche (Unir) N” WO 96/38587, [‘CT. La prksente invention concerne un pro&d& permettant la mise en ividence de Byssochlamys niLJea, LNeosrzrtor)k7 fischeri et Zygosaccbilrotnyces haili~ par amplification de I’ADN gknomique des microorganismes cibk en utilisant comme amorce une 95 quence cotnprise dans les espaceurs transcrits internes (ITS) de I’unitP ribosomique...

l

> Composition to improve digestibility and utilisation of nutrients (S Scharpe, BE)

Medzyme NV and the inventor N” WO 96138170. PCT. . comprising one or more acid stables lipases and/or one more acid stable amylases. Both the lipase and the amylase may be of fungal origin. The lipase preferably originates from Rhrzopus arrhizus or Rhizopus ja~w rfictrs and the amylnse from Aspergillt4s nigev. The composition is for example a pharmaceutical composition for use in the treatment of exocrine pancreas insufficiency which may be result or a side-effect of acquired chronic pancreatitis, alcoholisms, cystic fibrosis or pancreatic carcinomas. r Antimicrobial cationic peptides (R Hancock and N Karunartne, CA)

University of British Columbia N” WO 96138473. PCT. A novel class of cationic pcptides having antimicrobial activity is provided... The peptides are particularly useful for inhibiting endotoxaemia in a subject. > Antifungal and terial histatin-based tides (F Oppenheim US)

antibacpepet al,

Periodontix Inc, the Trustees of Boston University and the inventors N” WO 96140768. PCT. Human growth agent for adults et al, JP)

hormone (N Asada

Mitsui Toatsu Chemicals Inc N” 753307, EP.

> Monospecific and methods (JR Calaycay

antibodies using them et al, US)

Merck & Co Inc and the inventors N” WO 96140785, PCT. 1 Compositions containing an antibiotic and a peptide potentiating this antibiotic (M Porro and M Varra, IT, FI)

Biosynth Srl N” WO 96/38163, PCT. Th e present invention is concerned with methods of potentiating an antibiotic. The invention also includes compositions of an antibiotic and a peptide having units...

,.. The monospecific antibodies and the assays systems are used to quantitate hiNOS (human inducible nitric oxyde svnthase) as a readout of hiNOS activity and to evaluate potential hiNOS modulators. > Standardized, primary osteoblast cell cultures taken from patients suffering from osteoporosis, and the use of these cell

BIOFLJTUR 165 l Mars 1997 45

. . .